Ana Florescu
Impact in
-
- Air Quality and Health Impacts
- Physiology top 10%
- Smoking Behavior and Cessation
Papers in
- Oncology 5
- HER2/EGFR in Cancer Research 2
- Cancer Treatment and Pharmacology 1
-
- Smoking Behavior and Cessation 4
- Co-authors
- Gideon Koren (5 shared papers)Peter Selby (3 shared papers)Roberta Ferrence (3 shared papers)Tom Einarson (1 shared paper)Offie P. Soldin (1 shared paper)Adriana Moldovan Costei (1 shared paper)Myla E. Moretti (1 shared paper)Radinka Boskovic (1 shared paper)
In The Last Decade
Ana Florescu
13 papers receiving 577 citations
Peers
Comparison fields: 5 of 104
- Health, Toxicology and Mutagenesis 117
- Physiology 218
- Speech and Hearing 44
- Public Health, Environmental and Occupational Health 135
- Pediatrics, Perinatology and Child Health 89
Countries citing papers authored by Ana Florescu
This map shows the geographic impact of Ana Florescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Florescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Florescu more than expected).
Fields of papers citing papers by Ana Florescu
This network shows the impact of papers produced by Ana Florescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Florescu. The network helps show where Ana Florescu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Florescu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 274 | |
| 2 | 2006 | 144 | |
| 3 | 2007 | 57 | |
| 4 | 2011 | 34 | |
| 5 | 2013 | 27 | |
| 6 | 2011 | 24 | |
| 7 | 2009 | 23 | |
| 8 | 2005 | 9 | |
| 9 | 2021 | 7 | |
| 10 | Nonsteroidal anti-inflammatory drugs for rheumatoid arthritis during pregnancy. | 2005 | 3 |
| 11 | 2011 | 1 | |
| 12 | 2005 | 1 | |
| 13 | 2021 | 1 |
About Ana Florescu
Ana Florescu is a scholar working on Oncology, Physiology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology, having authored 13 papers that have together received 605 indexed citations. Recurring topics across this work include Smoking Behavior and Cessation (4 papers), Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers), Cardiovascular Issues in Pregnancy (2 papers), Air Quality and Health Impacts (2 papers), Cardiovascular Conditions and Treatments (2 papers), Cancer Genomics and Diagnostics (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Health, Toxicology and Mutagenesis (117 citations), Physiology (218 citations), Speech and Hearing (44 citations), Public Health, Environmental and Occupational Health (135 citations) and Pediatrics, Perinatology and Child Health (89 citations). Ana Florescu has collaborated with scholars based in Canada, India and France. Frequent co-authors include Gideon Koren, Peter Selby, Roberta Ferrence, Tom Einarson, Offie P. Soldin, Adriana Moldovan Costei, Myla E. Moretti, Radinka Boskovic, Eitan Amir and Mark Clemons. Their work appears in journals such as Therapeutic Drug Monitoring, Journal of Clinical Oncology, BMC Cancer, Journal of Occupational and Environmental Medicine and Annals of Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.